2017
DOI: 10.1097/olq.0000000000000638
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of Prenatal Screening and Treatment to Prevent Congenital Syphilis, Louisiana and Florida, 2013–2014

Abstract: Background: From 2012 to 2014, rates of congenital syphilis increased in Louisiana and Florida. We evaluated the effectiveness of early (first or second) and third trimester syphilis screening for the prevention of congenital syphilis in these high-morbidity states. Methods: Reported syphilis cases among pregnant women in Louisiana and Florida during January 1, 2013, to December 31, 2014, were reviewed for documented screening for syphilis in the first 2 trimesters and third trimester. Pregnant women with sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
40
1
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(46 citation statements)
references
References 23 publications
2
40
1
3
Order By: Relevance
“…To encourage early detection of syphilis in pregnant women, some states have mandated screening at the first prenatal care examination and during the early third trimester. Universal third-trimester screening effectively prevented most congenital syphilis cases in Florida and Louisiana ( 6 ); however, this strategy might not be cost-effective in low-morbidity areas ( 7 ).…”
Section: Discussionmentioning
confidence: 99%
“…To encourage early detection of syphilis in pregnant women, some states have mandated screening at the first prenatal care examination and during the early third trimester. Universal third-trimester screening effectively prevented most congenital syphilis cases in Florida and Louisiana ( 6 ); however, this strategy might not be cost-effective in low-morbidity areas ( 7 ).…”
Section: Discussionmentioning
confidence: 99%
“…[16,24,26] The same weeks gestation and delivery [7,16]. A study done in Florida and Louisiana following the guidelines in high risk pregnant women was able to pick up an additional 5% of CS cases by screening at 28 weeks and delivery for an additional treatment of 30 patients over first trimester screening only [31] However, despite the available data and clinical knowledge, the rates in the US and worldwide continue to rise and predominantly affects disadvantaged communities that have issues with poverty, substance abuse and lack of health care access. To date the US does not have a national program to mandate screening all pregnant women for CS, in fact there are still six states where there is no requirement and only a third of states require a third trimester screening [32] .…”
Section: Clinical Manifestationsmentioning
confidence: 99%
“…of syphilis during pregnancy, and is thus one of the most significant individual risk factors for CS. 2,6,[24][25][26][27] The CDC found that 28% of mothers of infants with CS from 1999 to 2013 received no PNC and an additional 32% received less than the recommended 10 PNC visits. 1 Third trimester screening based on regional epidemiological risk can be challenging in part because of imprecision of available data.…”
Section: Figurementioning
confidence: 99%